IFNA2 and viral infectious disease: This may suggest that pre-treating pigs with IFNα prior to EBOV exposure suppressed the cytokine storm caused immunopathology observed in the EBOV-infected pigs [25], heightened immunity against this viral infection, and substantially altered the nature of the immune response mounted by EBOV exposure, for example, by increasing T-and natural killer- cell responses.